...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AGM - High Level Summary
7
Jan 07, 2016 03:54PM
2
Jan 07, 2016 03:58PM
4
Jan 07, 2016 06:25PM
4
Jan 07, 2016 06:59PM
2
Jan 07, 2016 07:35PM
7
Jan 07, 2016 11:57PM
3
Jan 08, 2016 12:06AM
4
Jan 08, 2016 07:18AM
2
Jan 08, 2016 01:40PM
2
Jan 08, 2016 03:07PM
1
Jan 12, 2016 10:30AM
3
Jan 12, 2016 05:38PM
1
Jan 12, 2016 06:19PM

Jan 12, 2016 06:48PM
Hi KBC, Don said at the meeting that the 34 million shares (roughly) was basically some sort of accounting number and in the final version that will become 99 million (same as Zenith currently) in the final iteration, before any further investment in the newco. He said that it is being done in such away as to avoid a tax bill for shareholders and that if anyone wants a detailed explanation of the process they should call Brad Cann because Don said he can't explain it.
1
Jan 12, 2016 08:50PM
5
Jan 12, 2016 10:14PM
3
Jan 12, 2016 11:04PM
4
Jan 13, 2016 08:58AM
5
Jan 13, 2016 01:37PM
1
Jan 13, 2016 02:01PM
Share
New Message
Please login to post a reply